In addition, no significant change or elevation in the expression of SH3BGRL2 was found in STAD and ESCA samples while it was significantly overexpressed in COAD, READ and PAAD samples (Fig. 4a). This evidence concerns the gene SH3BGRL2 and pancreatic adenocarcinoma.